Literature DB >> 11311882

Enhanced leptin transport across the blood-brain barrier by alpha 1-adrenergic agents.

W A Banks1.   

Abstract

Leptin is a 16 kDa protein secreted by fat cells which regulates body weight and thermogenesis at sites within the brain. Blood-borne leptin reaches those brain sites because of a saturable transport system located at the blood-brain barrier (BBB). Impaired transport occurs in obese rodents and likely underlies the resistance to the actions of peripheral leptin seen in obesity. Here, we show that leptin transport into the brain is enhanced 2-3-fold by epinephrine and other agents which are more specific for the alpha1 adrenergic receptor. Epinephrine had no effect on the transport across the BBB of insulin or tumor necrosis factor, on BBB integrity, or on the size of the vascular space of the brain. Dopamine, acetylcholine, histamine, serotonin, thyroid hormones, and phentolamine were without effect. Of several amino acids tested, only the catecholamine precursor tyrosine had an effect on leptin transport. Epinephrine was effective after intravenous or intraperitoneal injection, but neither epinephrine nor any of the other monoamines given by intracerebroventricular injection had an effect on leptin transport. These results show that epinephrine likely acts at a site on the luminal surface of the BBB. In conclusion, epinephrine works at an alpha1-like adrenergic, luminal side to enhance the transport of leptin across the BBB.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11311882     DOI: 10.1016/s0006-8993(01)02242-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  26 in total

Review 1.  Brain meets body: the blood-brain barrier as an endocrine interface.

Authors:  William A Banks
Journal:  Endocrinology       Date:  2012-07-09       Impact factor: 4.736

2.  Pharmacologic manipulation of lysosomal enzyme transport across the blood-brain barrier.

Authors:  Akihiko Urayama; Jeffrey H Grubb; William S Sly; William A Banks
Journal:  J Cereb Blood Flow Metab       Date:  2015-11-03       Impact factor: 6.200

Review 3.  From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery.

Authors:  William A Banks
Journal:  Nat Rev Drug Discov       Date:  2016-01-22       Impact factor: 84.694

Review 4.  Mouse models of neurological disorders: a view from the blood-brain barrier.

Authors:  William A Banks
Journal:  Biochim Biophys Acta       Date:  2009-10-29

5.  The role of α1-adrenergic receptors in regulating metabolism: increased glucose tolerance, leptin secretion and lipid oxidation.

Authors:  Ting Shi; Robert S Papay; Dianne M Perez
Journal:  J Recept Signal Transduct Res       Date:  2016-06-08       Impact factor: 2.092

Review 6.  Dietary components in the development of leptin resistance.

Authors:  Joseph R Vasselli; Philip J Scarpace; Ruth B S Harris; William A Banks
Journal:  Adv Nutr       Date:  2013-03-01       Impact factor: 8.701

7.  Increased insulin sensitivity and reduced micro and macro vascular disease induced by 2-deoxy-D-glucose during metabolic syndrome in obese JCR: LA-cp rats.

Authors:  J C Russell; S D Proctor
Journal:  Br J Pharmacol       Date:  2007-03-20       Impact factor: 8.739

Review 8.  Principles of strategic drug delivery to the brain (SDDB): development of anorectic and orexigenic analogs of leptin.

Authors:  W A Banks; A Gertler; G Solomon; L Niv-Spector; M Shpilman; X Yi; E Batrakova; S Vinogradov; A V Kabanov
Journal:  Physiol Behav       Date:  2011-06-06

9.  Astrocyte leptin receptor (ObR) and leptin transport in adult-onset obese mice.

Authors:  Weihong Pan; Hung Hsuchou; Yi He; Amul Sakharkar; Courtney Cain; Chuanhui Yu; Abba J Kastin
Journal:  Endocrinology       Date:  2008-02-21       Impact factor: 4.736

10.  Effects of triglycerides, obesity, and starvation on ghrelin transport across the blood-brain barrier.

Authors:  William A Banks; Basil O Burney; Sandra M Robinson
Journal:  Peptides       Date:  2008-07-17       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.